Generics BulletinRecent weeks have seen Advanz Pharma make a number of portfolio-diversifying deals, including licensing and supply agreements and product acquisitions. Most notably, the company has acquired exclusi
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bayer, Twist Collaboration Gives German